NCT06909227 Relevance of Veinous Lactates to Predict Postoperative Complications in Children 0-1 Years
| NCT ID | NCT06909227 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hôpital Armand Trousseau |
| Condition | General Anesthesia |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2025-03-27 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2025-03-27 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will investigate if the dosage of veinous lactate at the end of a surgical procedure is related to post-operative complications occurring within 3 months in young infants aged 0-1 years. Blood samples are acquired routinely before emergence of general anesthesia, from the IV line put in place for anesthesia. The investigators hypothesized that elevated lactates would be associated with more postoperative complications in this population, as is the case in adults.
Eligibility Criteria
Inclusion Criteria: * surgery under general anesthesia * age \< 1 year Exclusion Criteria: * ambulatory surgery * cardiac surgery * preoperative hemodynamic instability * Weight \< 2 kg
Contact & Investigator
Nada Sabourdin, MD, PhD
STUDY DIRECTOR
Armand Trousseau University Hospital
Frequently Asked Questions
Who can join the NCT06909227 clinical trial?
This trial is open to participants of all sexes, aged 0 Years or older, up to 1 Year, studying General Anesthesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06909227 currently recruiting?
Yes, NCT06909227 is actively recruiting participants. Contact the research team at mireille.nasr@aphp.fr for enrollment information.
Where is the NCT06909227 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT06909227 clinical trial?
NCT06909227 is sponsored by Hôpital Armand Trousseau. The principal investigator is Nada Sabourdin, MD, PhD at Armand Trousseau University Hospital. The trial plans to enroll 500 participants.